Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)

ABSTRACT Purpose. The aim of study was to normalize the intraocular pressure for maintenance of residual visual functions of the patient operated for glaucoma secondary to active tubercular uveitis. Material and methods. A 53-year-old man suffers from tubercular-allergic uveitis duri...

Full description

Bibliographic Details
Main Authors: M.G. Gamzayev, O.N. Zuban
Format: Article
Language:Russian
Published: Publishing house "Ophthalmology" 2013-02-01
Series:Офтальмохирургия
Subjects:
Online Access:http://www.eyepress.ru/article.aspx?11592
_version_ 1828057628440264704
author M.G. Gamzayev,
O.N. Zuban
author_facet M.G. Gamzayev,
O.N. Zuban
author_sort M.G. Gamzayev,
collection DOAJ
description ABSTRACT Purpose. The aim of study was to normalize the intraocular pressure for maintenance of residual visual functions of the patient operated for glaucoma secondary to active tubercular uveitis. Material and methods. A 53-year-old man suffers from tubercular-allergic uveitis during more than 10 years, glaucoma was diagnosed since 2001. The previous surgical methods of treatment (laser trabeculoplasty, sinus trabeculectomy (STE) with basal iridectomy) were ineffective. During medicamentous therapy the intraocular pressure increased up to 28-32 mmHg. Visual acuity is 0.03, not corrected. Patient was treated with antituberculosis therapy consisted of three medicines (Phthivazidum 1.0; Pyrazinamide 1.5; Avelox 0.4). Patient underwent sinus trabeculectomy with a partial iridectomy and implantation of biodegradable drainage implant “Glautex” of High Be Tech Ltd. production (Register certificate FSR 2012/13098). Results. There were no complications during postoperative period. Intraocular pressure remained stable (17-19 mmHg by Maklakov) without ocular hypotensive therapy. There were no signs of recurrent uveitis, visual acuity was 0.03, not corrected. Conclusions. The biodegradable drainage implant “Glautex” can be inserted to patients with glaucoma secondary to active tubercular uveitis owing to its high biocompatibility with the cellular structures of human tissues and controlled bio-absorbable properties.
first_indexed 2024-04-10T21:15:11Z
format Article
id doaj.art-54848691a7ad4422b76c5b1a60a0848e
institution Directory Open Access Journal
issn 0235-4160
0235-4160
language Russian
last_indexed 2024-04-10T21:15:11Z
publishDate 2013-02-01
publisher Publishing house "Ophthalmology"
record_format Article
series Офтальмохирургия
spelling doaj.art-54848691a7ad4422b76c5b1a60a0848e2023-01-20T12:34:50ZrusPublishing house "Ophthalmology"Офтальмохирургия0235-41600235-41602013-02-0125254Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)M.G. Gamzayev,0O.N. Zuban1The State Public Healthcare Institution, Clinic No.2, MoscowThe State Public Healthcare Institution, Clinic No.2, MoscowABSTRACT Purpose. The aim of study was to normalize the intraocular pressure for maintenance of residual visual functions of the patient operated for glaucoma secondary to active tubercular uveitis. Material and methods. A 53-year-old man suffers from tubercular-allergic uveitis during more than 10 years, glaucoma was diagnosed since 2001. The previous surgical methods of treatment (laser trabeculoplasty, sinus trabeculectomy (STE) with basal iridectomy) were ineffective. During medicamentous therapy the intraocular pressure increased up to 28-32 mmHg. Visual acuity is 0.03, not corrected. Patient was treated with antituberculosis therapy consisted of three medicines (Phthivazidum 1.0; Pyrazinamide 1.5; Avelox 0.4). Patient underwent sinus trabeculectomy with a partial iridectomy and implantation of biodegradable drainage implant “Glautex” of High Be Tech Ltd. production (Register certificate FSR 2012/13098). Results. There were no complications during postoperative period. Intraocular pressure remained stable (17-19 mmHg by Maklakov) without ocular hypotensive therapy. There were no signs of recurrent uveitis, visual acuity was 0.03, not corrected. Conclusions. The biodegradable drainage implant “Glautex” can be inserted to patients with glaucoma secondary to active tubercular uveitis owing to its high biocompatibility with the cellular structures of human tissues and controlled bio-absorbable properties.http://www.eyepress.ru/article.aspx?11592glaucomadrainagesinus trabeculectomy (STE)tuberculosisimplant Glautex
spellingShingle M.G. Gamzayev,
O.N. Zuban
Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)
Офтальмохирургия
glaucoma
drainage
sinus trabeculectomy (STE)
tuberculosis
implant Glautex
title Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)
title_full Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)
title_fullStr Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)
title_full_unstemmed Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)
title_short Surgical treatment of secondary glaucoma in active tubercular uveitis (a case report)
title_sort surgical treatment of secondary glaucoma in active tubercular uveitis a case report
topic glaucoma
drainage
sinus trabeculectomy (STE)
tuberculosis
implant Glautex
url http://www.eyepress.ru/article.aspx?11592
work_keys_str_mv AT mggamzayev surgicaltreatmentofsecondaryglaucomainactivetubercularuveitisacasereport
AT onzuban surgicaltreatmentofsecondaryglaucomainactivetubercularuveitisacasereport